Paper36588262
Pilocarpine 1.25% for the treatment of presbyopia.
Mansoori T. Indian J Ophthalmol, 2023. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Pilocarpine 1.25% for the treatment of presbyopia. Papers, record 36588262. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36588262
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Presbyopia | Major topic |
| Lens, Crystalline | Major topic |
| Humans | |
| Pilocarpine | |
| Accommodation, Ocular |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment on | 35238902 | Safety and Efficacy of AGN-190584 in Individuals With Presbyopia: The GEMINI 1 Phase 3 Randomized Clinical Trial. | https://conductscience.org/library/papers/35238902 |
Source PubMed
References5
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35238902 | Safety and Efficacy of AGN-190584 in Individuals With Presbyopia: The GEMINI 1 Phase 3 Randomized Clinical Trial. | JAMA Ophthalmol | 2022 | https://conductscience.org/library/papers/35238902 | PubMed |
| 2 | 578368 | In vitro investigations on the effect of pilocarpine on the metabolism in pig lenses illustrated with some intermediate metabolites. | Acta Ophthalmol (Copenh) | 1977 | https://conductscience.org/library/papers/578368 | PubMed |
| 3 | 760777 | The trabecular wall of Schlemm's canal: a study of the effects of pilocarpine by scanning electron microscopy. | Br J Ophthalmol | 1979 | https://conductscience.org/library/papers/760777 | PubMed |
| 4 | 5793665 | The effects of miotics on anterior-chamber depth. | Am J Ophthalmol | 1969 | https://conductscience.org/library/papers/5793665 | PubMed |
| 5 | 4196286 | Pilocarpine uptake by pigmented uveal tissue. | Am J Ophthalmol | 1973 | https://conductscience.org/library/papers/4196286 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40880143 | Efficacy and safety of pilocarpine hydrochloride ophthalmic solution USP 1.25% w/v versus placebo ophthalmic solution for the treatment of presbyopia - A multicentric clinical trial. | Indian J Ophthalmol | 2025 | https://conductscience.org/library/papers/40880143 | PubMed |
| 39982101 | Comments on "the effect of 2% pilocarpine on depth of field in different time intervals among presbyopic subjects". | Indian J Ophthalmol | 2025 | https://conductscience.org/library/papers/39982101 | PubMed |
| 39187764 | Case report: Topical pilocarpine ameliorated the accommodation loss and pupillary dilation after micropulse transscleral laser treatment. | BMC Ophthalmol | 2024 | https://conductscience.org/library/papers/39187764 | PubMed |
| 38592033 | Effects of Miosis on the Visual Acuity Space under Varying Conditions of Contrast and Ambient Luminance in Presbyopia. | J Clin Med | 2024 | https://conductscience.org/library/papers/38592033 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36588262
GET https://conductscience.org/api/papers/v1/36588262/authors